Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125747161 | 12574716 | 1 | I | 201601 | 20160718 | 20160720 | 20160720 | EXP | CO-PFIZER INC-2016352297 | PFIZER | 8.00 | YR | M | Y | 0.00000 | 20160720 | CN | CO | CO |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125747161 | 12574716 | 1 | PS | GENOTROPIN | SOMATROPIN | 1 | Subcutaneous | 0.6 MG, DAILY | 20280 | .6 | MG | SOLUTION FOR INJECTION |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125747161 | 12574716 | 1 | Growth hormone deficiency |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125747161 | 12574716 | HO |
| 125747161 | 12574716 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125747161 | 12574716 | Asthenia | |
| 125747161 | 12574716 | Cerebrovascular accident | |
| 125747161 | 12574716 | Gait disturbance | |
| 125747161 | 12574716 | Headache | |
| 125747161 | 12574716 | Hypoaesthesia | |
| 125747161 | 12574716 | Intellectual disability | |
| 125747161 | 12574716 | Pain |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125747161 | 12574716 | 1 | 2015 | 0 |